Scientists say they have built a cell from scratch for the first time that feeds, grows and replicates like a natural cell, a ...
FDA cleared Tregzi to improve chronic GVHD-free survival, representing a non-pharmacologic strategy to reduce chronic GVHD while supporting immune reconstitution after allogeneic transplantation.
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results